An experimental medical chatbot based on a large language model (LLM) developed by Google has been shown to be more accurate than primary-care doctors in diagnosing some i
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh